Author Correction: Subsets of exhausted CD8


Journal

Nature immunology
ISSN: 1529-2916
Titre abrégé: Nat Immunol
Pays: United States
ID NLM: 100941354

Informations de publication

Date de publication:
Nov 2019
Historique:
pubmed: 5 10 2019
medline: 5 10 2019
entrez: 5 10 2019
Statut: ppublish

Résumé

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiants

pubmed: 31582823
doi: 10.1038/s41590-019-0528-5
pii: 10.1038/s41590-019-0528-5
pmc: PMC7461603
mid: NIHMS1617855
doi:

Types de publication

Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

1556

Subventions

Organisme : NCI NIH HHS
ID : T32 CA207021
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM007753
Pays : United States

Commentaires et corrections

Type : ErratumFor

Auteurs

Brian C Miller (BC)

Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.
Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.

Debattama R Sen (DR)

Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Division of Medical Sciences, Harvard Medical School, Boston, MA, USA.

Rose Al Abosy (R)

Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Kevin Bi (K)

Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Yamini V Virkud (YV)

Division of Pediatric Allergy and Immunology, Massachusetts General Hospital, Boston, MA, USA.

Martin W LaFleur (MW)

Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.
Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
Division of Medical Sciences, Harvard Medical School, Boston, MA, USA.

Kathleen B Yates (KB)

Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Ana Lako (A)

Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

Kristen Felt (K)

Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

Girish S Naik (GS)

Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

Michael Manos (M)

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

Evisa Gjini (E)

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

Juhi R Kuchroo (JR)

Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.
Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
Division of Medical Sciences, Harvard Medical School, Boston, MA, USA.

Jeffrey J Ishizuka (JJ)

Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Jenna L Collier (JL)

Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.
Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
Division of Medical Sciences, Harvard Medical School, Boston, MA, USA.

Gabriel K Griffin (GK)

Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.

Seth Maleri (S)

Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.
Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.

Dawn E Comstock (DE)

Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Division of Medical Sciences, Harvard Medical School, Boston, MA, USA.

Sarah A Weiss (SA)

Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Division of Medical Sciences, Harvard Medical School, Boston, MA, USA.

Flavian D Brown (FD)

Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.
Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
Division of Medical Sciences, Harvard Medical School, Boston, MA, USA.

Arpit Panda (A)

Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Margaret D Zimmer (MD)

Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Robert T Manguso (RT)

Broad Institute of MIT and Harvard, Cambridge, MA, USA.

F Stephen Hodi (FS)

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

Scott J Rodig (SJ)

Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.

Arlene H Sharpe (AH)

Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.
Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
Division of Medical Sciences, Harvard Medical School, Boston, MA, USA.

W Nicholas Haining (WN)

Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. wnhaining@gmail.com.
Broad Institute of MIT and Harvard, Cambridge, MA, USA. wnhaining@gmail.com.
Division of Medical Sciences, Harvard Medical School, Boston, MA, USA. wnhaining@gmail.com.

Classifications MeSH